Suppr超能文献

在大鼠心脏移植模型中,缺血/再灌注损伤介导的腺病毒介导基因表达下调可通过联合应用TNFRp55-Ig嵌合构建体得到抑制。

Ischemia/reperfusion injury-mediated down-regulation of adenovirus-mediated gene expression in a rat heart transplantation model is inhibited by co-application of a TNFRp55-Ig chimeric construct.

作者信息

Ritter T, Schröder G, Risch K, Vergopoulos A, Shean M K, Kolls J, Brock J, Lehmann M, Volk H D

机构信息

Institute of Medical Immunology, Charité, Humboldt University Berlin, Germany.

出版信息

Gene Ther. 2000 Jul;7(14):1238-43. doi: 10.1038/sj.gt.3301222.

Abstract

E1-deleted adenoviral vectors are efficient vectors for somatic gene therapy. Recently, we have shown that intratracheal application of an adenoviral reporter construct leads to significant reporter gene expression in rat lungs within 24 h. In contrast, reporter gene expression in syngeneic rat heart transplants after adenovirus-mediated gene transfer was delayed. Since the adenovirus cannot replicate, down-regulation of the hCMV-IE promoter controlled reporter gene expression in initially infected cells by cytokines, which are released as a result of ischemia/reperfusion injury, might be involved. In order to investigate the role of proinflammatory cytokines, eg TNF-alpha in affecting hCMV-IE promoter-driven reporter gene expression, transient blockade of TNF-alpha was achieved by local co-application of an Ad-construct encoding for a soluble TNFRp55-Ig chimeric molecule in a syngeneic rat heart transplantation model. Co-application of the reporter construct together with the TNFRp55-Ig chimeric molecule significantly increased the early reporter gene expression after transplantation. Moreover, infiltration of inflammatory cells (T cells, macrophages, NK cells) and production of TNF-alpha in the transplant was markedly reduced. Our results indicate that: (1) proinflammatory cytokines are involved in down-regulation of reporter gene expression in ischemia/reperfusion injured tissues; and (2) inhibition of TNF-alpha might be a useful tool to increase early gene expression in gene therapy protocols, particularly in transplantation. Gene Therapy (2000) 7, 1238-1243.

摘要

E1 缺失的腺病毒载体是用于体细胞基因治疗的有效载体。最近,我们发现气管内应用腺病毒报告基因构建体可在 24 小时内使大鼠肺组织中报告基因显著表达。相比之下,腺病毒介导的基因转移后,同基因大鼠心脏移植中的报告基因表达则出现延迟。由于腺病毒无法复制,缺血/再灌注损伤释放的细胞因子可能会下调最初感染细胞中由人巨细胞病毒早期增强子(hCMV-IE)启动子控制的报告基因表达。为了研究促炎细胞因子(如肿瘤坏死因子-α,TNF-α)在影响 hCMV-IE 启动子驱动的报告基因表达中的作用,在同基因大鼠心脏移植模型中,通过局部共同应用编码可溶性 TNFRp55-Ig 嵌合分子的腺病毒构建体实现了对 TNF-α 的短暂阻断。报告基因构建体与 TNFRp55-Ig 嵌合分子共同应用显著增加了移植后早期报告基因的表达。此外,移植组织中炎性细胞(T 细胞、巨噬细胞、NK 细胞)的浸润和 TNF-α 的产生明显减少。我们的结果表明:(1)促炎细胞因子参与了缺血/再灌注损伤组织中报告基因表达的下调;(2)抑制 TNF-α 可能是增加基因治疗方案中早期基因表达的有用工具,特别是在移植中。《基因治疗》(2000 年)7 卷,1238 - 1243 页。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验